SI
RXDX

Sofinnova Investments’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Sofinnova Investments’s Portfolio RXDX Stock Details RXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-123,842
Closed -$13.3M – 62
2023
Q1 		$13.3M Sell
123,842
-52,703
-30% -$5.66M 0.85% 28
2022
Q4 		$19.4M Buy
176,545
+36,771
+26% +$4.04M 1.15% 21
2022
Q3 		$8.25M Sell
139,774
-246,621
-64% -$14.6M 0.48% 31
2022
Q2 		$10.9M Buy
+386,395
New +$10.9M 0.91% 25